Kyivmedpreparat Logo

Kyivmedpreparat

A leading pharmaceutical producer of antibacterial, generic, and original medicines in various forms.

KMED | Ukrainian Stock Exchange

Overview

Corporate Details

ISIN(s):
UA4000106140
LEI:
Country:
Ukraine
Address:
139 Saksaganskogo Str., 01032 Kyiv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kyivmedpreparat, a part of Arterium Corporation, is a pharmaceutical company that manufactures a wide range of medicinal products. The company is a leading national producer of antibacterial drugs and also offers a broad portfolio of generic and original medicines. Its products are manufactured in various forms, including powders for injection, tablets, capsules, soft medicinal products, and granules for oral solutions. The company focuses on developing patient-centric solutions, providing high-quality medicines, and supporting patients throughout their treatment.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Kyivmedpreparat filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kyivmedpreparat

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kyivmedpreparat via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IO Biotech, Inc. Logo
Develops dual-action, off-the-shelf therapeutic cancer vaccines for solid tumors.
United States of America
IOBT
IONIS PHARMACEUTICALS INC Logo
A leader in antisense technology, developing RNA-targeted drugs for neurology and cardiology.
United States of America
IONS
IOVANCE BIOTHERAPEUTICS, INC. Logo
Developing personalized T-cell immunotherapies (TIL) to fight solid tumors and blood cancers.
United States of America
IOVA
Ipsen Logo
Developing innovative medicines for Oncology, Rare Diseases, and Neuroscience.
France
IPN
IRLAB Therapeutics Logo
Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.
Sweden
IRLAB
IRONWOOD PHARMACEUTICALS INC Logo
Develops and commercializes therapies for GI diseases like IBS-C and chronic constipation.
United States of America
IRWD
ISU Abxis Co., Ltd. Logo
Developing antibody-based immunotherapies for oncology and rare diseases.
South Korea
086890
Iterum Therapeutics plc Logo
Develops novel oral & IV anti-infectives to combat multi-drug resistant pathogens.
United States of America
ITRM
Jaguar Health, Inc. Logo
Develops plant-based, non-opioid GI therapies for humans and animals.
United States of America
JAGX
Janux Therapeutics, Inc. Logo
Developing tumor-activated immunotherapies to treat cancer while minimizing systemic toxicities.
United States of America
JANX

Talk to a Data Expert

Have a question? We'll get back to you promptly.